Informed Consent: Enforcing Pharmaceutical Companies' Obligations Abroad

Simple item page
dc.contributor.authorLee, Stacey B.
dc.date.accessioned2009-11-04T18:30:43Z
dc.date.available2009-11-04T18:30:43Z
dc.date.issued2009-11
dc.description.abstractThe past several years have seen an evolution in the obligations of pharmaceutical companies conducting clinical trials abroad. Key players, such as international human rights organizations, the United States government and courts, and the media have played a significant role in defining those obligations. This article examines the evolution of those obligations through the lens of past, present, and future recommendations for informed consent protections. In doing so, this article suggests that, no matter how robust these obligations become on their face, they will continue to fall short of providing meaningful protection until they are accompanied by a substantive enforcement mechanism that holds multinational pharmaceutical companies accountable for their conduct. Issues of national sovereignty, particularly in the United States, will continue to prevent meaningful enforcement from an international tribunal or from one universally adopted code of ethics. Rather than continuing to pursue an untenable international approach, this article argues that a viable enforcement mechanism lies in application of the Alien Torts Statute (ATS). Recent federal appellate court precedent interpreting the ATS provides the mechanism for granting victim redress and enforcing sponsor accountability for informed consent misconduct. A vital component in ensuring the world population’s “right to health” includes substantive human rights protections. This article concludes that by building on the federal appellate court’s ATS analysis, which grants foreign trial participants the right to pursue claims of human rights violations in the United States, a mechanism for enforcing not only substantive informed consent, but also human rights protections can be created.en_US
dc.identifier.urihttp://jhir.library.jhu.edu/handle/1774.2/33526
dc.language.isoen_USen_US
dc.publisherCarey Business School, Johns Hopkins Universityen_US
dc.relation.ispartofseriesThe Johns Hopkins Carey Business School Working Paper Series;09-11-001
dc.subjectK33 - International Lawen_US
dc.subjectK32 - Environmental, Health, and Safety Lawen_US
dc.titleInformed Consent: Enforcing Pharmaceutical Companies' Obligations Abroaden_US
dc.typeWorking Paperen_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Stacey Lee - Informed Consent - Pharmaceutical Obligations (2).pdf
Size:
112.96 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.81 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Working Papers